Elite Pharmaceuticals (ELTP) Research & Development (2009 - 2026)
Elite Pharmaceuticals (ELTP) recorded Research & Development of $1.88 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 35.5% from $1.39 million a year earlier but down 7.7% from the prior quarter.
Elite Pharmaceuticals (ELTP) Research & Development (2009 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Research & Development came in at $6.59 million as of Sep 30, 2026, down 4.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $5.74 million, down 27.9% from FY2025.
- Annual Research & Development has a five-year compound annual growth rate of 2.4% (FY2021 to FY2026).
- Across earlier fiscal years, Research & Development came in at $7.96 million in FY2025 (+15.7%), $6.88 million in FY2024 (+11.0%), $6.2 million in FY2023 (+53.0%) and $4.05 million in FY2022 (-20.8%).
- Quarterly Research & Development has ranged from $738,809 in fiscal Q4 2022 to $2.62 million in fiscal Q2 2024 over the past five years.
- On a year-over-year basis, Research & Development rose in four of the last eight quarters, with an average decline of 1.3%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 228.2% in fiscal Q4 2023, against a decline of 58.4% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $2.03 million (Q1 2027), $1.64 million (Q4 2026) and $1.04 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,293.04 Bn | 1,266.66 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 686.83 Bn | 606.69 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 525.76 Bn | 493.76 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.73 Bn | 325.68 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 313.98 Bn | 287.22 Bn | - | - |
| 6 | Astrazeneca | 287.17 Bn | 260.69 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 253.65 Bn | 205.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 210.81 Bn | 185.92 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.44 Bn | 112.80 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Elite Pharmaceuticals | 373.77 Mn | 247.18 Mn | 15.99 Mn | 1.88 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.88 Mn |
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 955,443.00 |
| Mar 31, 2022 | 738,809.00 |
| Dec 31, 2021 | 956,628.00 |
Elite Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();